Researchers at the Medical University of South Carolina have achieved a breakthrough that could transform diabetes treatment: engineered stem cells that successfully reverse new-onset type 1 diabetes in mice.

The promising development, published in the journal Molecular Therapy, represents a significant step forward in regenerative medicine. While the research is still in its early stages with animal models, it demonstrates that targeted stem cell therapy might one day help patients regain their body's ability to manage blood sugar naturally—potentially offering relief to the millions living with type 1 diabetes worldwide. Read the full story →

Today's takeaway: Science is moving closer to treatments that don't just manage diabetes, but could actually reverse it.